Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging
NCT ID: NCT04852471
Last Updated: 2023-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2022-01-05
2023-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electronic Reporting of Symptoms After Surgery
NCT02700256
Improving Cancer On-treatment Symptom Management
NCT04589247
Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients
NCT03178045
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
NCT04986566
Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery
NCT03456167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Post-Operative Counseling + FACT-G (Control Arm)
Patients will receive the standard postoperative counseling at discharge, discharge instructions, and the link to website with postoperative instructions. Patients will complete the Functional Assessment of Cancer Therapy - General (FACT-G).
Standard Post-Operative Counseling + FACT-G
Counseling at discharge + FACT-G at enrollment, at 15-18 and at 30-32 days post-operative.
Standard Post-Operative Counseling + PROM survey + FACT-G (Intervention Arm)
Patients will receive the standard postoperative counseling at discharge, discharge instructions, and the link to website with postoperative instructions. The intervention arm will receive and complete the Patient-Reported Outcome Measure (PROM) survey via the SMS text messaging service on a set schedule. Patients will complete the FACT-G.
Standard Post-Operative Counseling + FACT-G
Counseling at discharge + FACT-G at enrollment, at 15-18 and at 30-32 days post-operative.
PROM symptom tracker
A 12-item symptom tracker adopted from the Patient Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (NCI-PRO-CTCAE), delivered via text, on days 4, 6, 8, 12, 18, 24, and 30 post surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Post-Operative Counseling + FACT-G
Counseling at discharge + FACT-G at enrollment, at 15-18 and at 30-32 days post-operative.
PROM symptom tracker
A 12-item symptom tracker adopted from the Patient Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (NCI-PRO-CTCAE), delivered via text, on days 4, 6, 8, 12, 18, 24, and 30 post surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planning to undergo a surgical procedure via a laparotomy incision for a suspected or known gynecologic malignancy. There is no restriction on the spectrum of pathology or disease.
* The ability and willingness to send and receive short messaging service (SMS) text messages.
* Able to read and understand English.
* Willing and able to provide informed consent
Exclusion Criteria
* Persons unable to be contacted by SMS text message or choose to opt-out of the study.
* Patients who do not have access to the internet via a home computer or a smart phone.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan Rogel Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shitanshu Uppal, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00190175
Identifier Type: OTHER
Identifier Source: secondary_id
UMCC 2020.173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.